Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yuasa, K.
Right arrow Articles by Yanaka, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yuasa, K.
Right arrow Articles by Yanaka, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 7, 4897-4905, February 18, 2000


Binding and Phosphorylation of a Novel Male Germ Cell-specific cGMP-dependent Protein Kinase-anchoring Protein by cGMP-dependent Protein Kinase Ialpha *

Keizo YuasaDagger , Kenji OmoriDagger , and Noriyuki Yanaka§

From the Dagger  Discovery Research Laboratory, Tanabe Seiyaku Co. Ltd., 2-50 Kawagishi 2-chome, Toda, Saitama 335-8505 and the § Discovery Research Laboratory, Tanabe Seiyaku Co. Ltd., 16-89 Kashima 3-chome, Yodogawa-ku, Osaka 532-8505, Japan

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

cGMP-dependent protein kinase (cGK) is a major cellular receptor of cGMP and plays important roles in cGMP-dependent signal transduction pathways. To isolate the components of the cGMP/cGK signaling pathway such as substrates and regulatory proteins of cGK, we employed the yeast two-hybrid system using cGK-Ialpha as a bait and isolated a novel male germ cell-specific 42-kDa protein, GKAP42 (42-kDa cGMP-dependent protein kinase anchoring protein). Although the N-terminal region (amino acids 1-66) of cGK-Ialpha is sufficient for the association with GKAP42, GKAP42 could not interact with cGK-Ibeta , cGK-II, or cAMP-dependent protein kinase. GKAP42 mRNA is specifically expressed in testis, where it is restricted to the spermatocytes and early round spermatids. Endogenous cGK-I is co-immunoprecipitated with anti-GKAP42 antibody from mouse testis tissue, suggesting that cGK-I physiologically interacts with GKAP42. Immunocytochemical observations revealed that GKAP42 is localized to the Golgi complex and that cGK-Ialpha is co-localized to the Golgi complex when coexpressed with GKAP42. Although both cGK-Ialpha and -Ibeta , but not cAMP-dependent protein kinase, phosphorylated GKAP42 in vitro, GKAP42 was a good substrate only for cGK-Ialpha in intact cells, suggesting that the association with kinase protein is required for the phosphorylation in vivo. Finally, we demonstrated that the kinase-deficient mutant of cGK-Ialpha stably associates with GKAP42 and that binding of cGMP to cGK-Ialpha facilitates their release from GKAP42. These findings suggest that GKAP42 functions as an anchoring protein for cGK-Ialpha and that cGK-Ialpha may participate in germ cell development through phosphorylation of Golgi-associated proteins such as GKAP42.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

cGMP, which is produced in response to NO and natriuretic peptides, plays important roles in the regulation of smooth muscle relaxation, platelet aggregation, intestinal secretion, and endochondral ossification via the activation of cGMP-dependent protein kinases (cGKs)1 (1-4). cGK is a member of a family of cyclic nucleotide-dependent protein kinases that also includes cAMP-dependent protein kinase (cAK). Previous studies have identified two forms of cGK (I and II) that are encoded by distinct genes and two different isoforms of cGK-I (designated Ialpha and Ibeta ) that are produced by alternative splicing (5). The regulatory compartment located in the N-terminal region of cGK-I isozymes contains the leucine zipper motif and autoinhibitory domain, followed by two cGMP-binding and catalytic domains. In addition to the structural similarity between cGK and cAK (6), these kinases have many overlapping consensus phosphorylation motifs. Although possible substrates for cGK are often efficiently phosphorylated by cAK in vitro, the relatively low cytosolic concentration of cGK in most cells suggests that mechanisms other than recognition of consensus phosphorylation motifs may contribute to selective cGMP-mediated protein phosphorylation in intact cells. Recent reports indicate that specific anchoring proteins located at various sites in the cell compartmentalize the kinase proteins to their sites of action and that the location of anchoring proteins provides some of the specificity of the responses mediated by each kinase (7, 8). cAK is one of the best characterized protein kinases and has been shown to bind to specific anchoring proteins that are termed AKAPs (for A kinase anchoring proteins) through the regulatory subunits (9, 10). The cAK holoenzyme is a heterotetramer composed of a regulatory subunit dimer that associates with two catalytic subunits. Binding of cAMP to the regulatory subunits of cAK releases the active catalytic subunits, enabling them to interact with and phosphorylate their substrates. Therefore, the localization of cAK near its substrates may be important for rapid phosphorylation of specific substrate in response to increases in the intracellular concentration of cAMP. Similarly, when members of the protein kinase C family are activated, they undergo translocation from one intracellular compartment to another. A recent report has demonstrated that receptors for activated protein kinase C (RACK) anchor protein kinase C in the activated states and determine their subcellular localization (11). For instance, RACK1, a 36-kDa protein isolated from rat brain, binds to activated protein kinase Cbeta II and increases substrate phosphorylation by protein kinase C (12). In addition, evidence for other proteins being localized in the cell with substrates has been presented for Raf (13).

To investigate the potential functions of cGK-I isozymes and to determine the mechanism by which these functions are carried out, we have employed the yeast two-hybrid system to isolate the components of the cGMP/cGK signaling pathway such as substrates and regulatory proteins of cGK. Because AKAPs have been shown to associate with the regulatory subunits of cAK in the inactive state, we used the regulatory region located in the N terminus of cGK-Ialpha as a bait. Here we report evidence that cGK-Ialpha directly interacts with and phosphorylates the novel male germ cell-specific protein GKAP42 in vitro and in vivo. The interaction of cGK-Ialpha with GKAP42 facilitated the translocation of cGK-Ialpha to the Golgi complex, and cGK-Ialpha was released in response to intracellular cGMP accumulation. In the male germ cells, the Golgi complex is considered to be important for the formation of the acrosomic system and chromatoid body. These findings suggest that GKAP42 functions as an anchoring protein for cGK-Ialpha and that cGK-Ialpha might have functions through the interaction with Golgi-associated proteins during spermatogenesis.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- The MATCHMAKER II two-hybrid system and the mouse 17-day embryo MATCHMAKER cDNA library were obtained from CLONTECH. Restriction endonucleases and DNA-modifying enzymes were purchased from Takara Shuzo (Kyoto, Japan). COS-7 cells were from Dainippon Pharmaceutical Co. (Osaka, Japan). Dulbecco's modified Eagle's medium and fetal bovine serum were obtained from Life Technologies, Inc. [gamma -32P]ATP and Hybond-N+ were products of Amersham Pharmacia Biotech.

Plasmid Construction-- The full-length bovine cGK-Ialpha cDNA was a gift from Dr. Thomas M. Lincoln (University of Alabama at Birmingham). A cDNA encoding full-length cGK-Ialpha or its N-terminal region (amino acids 1-416) was subcloned into the BamHI (made blunt with T4 DNA polymerase) site of the yeast expression vector pAS2-1 (CLONTECH) fused in frame with the DNA-binding domain of the yeast transcriptional activator GAL4, generating pAS2-1-cGK-Ialpha or pAS2-1-cGK-Ialpha N, respectively. Deletion mutants of cGK-Ialpha were constructed by digestion of pAS2-1-cGK-Ialpha with appropriate restriction enzymes. Site-directed mutagenesis was performed using the QuickChangeTM site-directed mutagenesis kit (Stratagene) according to the protocol of the manufacturer as we described previously (14). To introduce the desired mutations, the following primers were used: 5'-ATTCCCCAGAAATCCGCCCATTCCATTTGCAAT-3' and 5'-ATTGCAAATGGAATGGGCGGATTTCTGGGGAAT-3' (S86A); 5'-CCAGCACAGAAGGAGGCACGGGAAGAAAACTGG-3' and 5'-CCAGTTTTCTTCCCGTGCCTCCTTCTGTGCTGG-3' (S106A); and 5'-AAGGACAAACCTGTCGCGGTGTCACTCAAAGAC-3' and 5'-GTCTTTGAGTGACACCGCGACAGGTTTGTCCTT-3' (T178A). The full-length human cGK-II cDNA was a kind gift from Dr. Michihiko Fujii (Kihara Institute for Biological Research, Yokohama City University). To obtain the full-length cDNA encoding human cGK-Ibeta , a reverse transcriptase-polymerase chain reaction (PCR) was applied using a human lung poly(A)+ RNA (CLONTECH) and a PCR primer set (5'-CCATGGGCACCTTGCGGGATTTACAG-3' and 5'-TTGCTGGCAGCTGTGTCTTAGAAAAAGC-3') designed according to the nucleotide sequences of human cGK-Ibeta (15). To clone the full-length cDNA encoding cAK regulatory and catalytic subunits, we performed reverse transcriptase-PCR using a mouse testis poly(A)+ RNA prepared by acid guanidium/phenol/chloroform extraction and an mRNA separator kit (CLONTECH). Two PCR primer sets (5'-ATGAGCCACATCCAGATCCCGCCGGGGCTC-3' and 5'-TTTCTAAATGCCCTTAACCACAGCAATGGCAGC-3'; and 5'-CCATGGGCAACGCCGCCGCCGCCAAGAAGGGC-3' and 5'-GGATCCTAAAACTCAGTAAACTCCTTGCCACACTT-3') were designed according to the nucleotide sequences of mouse cAK regulatory subunit IIalpha (16, 17) and catalytic subunit alpha  (18), respectively. The cDNA clone that encodes full-length human cardiac troponin I was provided by Dr. Yuichiro Maeda. The reverse transcriptase reaction was carried out using random hexamers at 42 °C for 60 min following the instructions included with the GeneAmp RNA PCR Core kit (PE Biosystems). PCR amplification was carried out through 30 cycles of denaturation at 94 °C for 1 min, annealing at 50 °C for 2 min, and extension at 72 °C for 3 min. All PCR products were cloned into the TA cloning vector pGEM-T-Easy (Promega), and then the sequences of DNA fragments were confirmed by DNA sequencing.

Yeast Two-hybrid Screening-- Yeast two-hybrid screening was performed as recommended by the manufacturer. In brief, the yeast strain Y190 was cotransformed with pAS2-1-cGK-Ialpha N and the mouse 17-day embryo cDNA library in pGAD10 using the lithium acetate method. Transformants were selected on synthetic dropout agar plates lacking tryptophan, leucine, and histidine, but including 25 mM 3-aminotriazole. Yeast colonies were transferred onto nylon membrane and processed by the beta -galactosidase filter assay. Plasmid DNA was isolated from positive colonies and retransformed into yeast strain Y190 with either pAS2-1 empty vector or pAS2-1-cGK-Ialpha N. The beta -galactosidase assay was again conducted to ensure the cGK-Ialpha -dependent activity. The cDNA inserts from true positive clones were sequenced by dideoxy chain termination methods using an Applied Biosystems Model 373A automated sequencer and a dye terminator cycle sequencing kit (PE Biosystems).

Screening of cDNA Library-- To isolate the complete cDNA of GKAP42, library screening was performed according to the standard procedure. A 210-base pair fragment (nucleotides 854-1063) of GKAP42 cDNA was radiolabeled using a random primer labeling kit (Takara Shuzo). Plaques of the mouse lung cDNA library (CLONTECH) plated onto 12 plates at ~5 × 104 plaque-forming units/plate were lifted using Hybond-N+ membrane and then screened by hybridization with a 32P-labeled probe in 6× SSC (1× SSC: 0.15 M NaCl and 15 mM sodium citrate, pH 7.0), 0.5% SDS, 5× Denhardt's solution (1 × Denhardt's solution: 0.02% each bovine serum albumin, polyvinylpyrrolidone, and Ficoll 400), and 100 µg/ml salmon sperm DNA at 65 °C for 16 h. The filters were washed with 2× SSC and 0.5% SDS at room temperature for 10 min, followed by two 30-min washes with 0.1× SSC and 0.5% SDS at 65 °C. The filters were exposed to x-ray film at -70 °C for 1 day. The inserted DNA digested with EcoRI was subcloned into pBluescript II SK(+) (Stratagene), and its nucleotide sequence was determined. Nucleotide sequences were analyzed by searching the GenBankTM Data Bank with BLAST. Coiled-coil graphs were made from data generated by the COILS algorithm (Version 2.1) (19).

Northern Blot Analysis-- A mouse multiple-tissue Northern blot (CLONTECH) was hybridized with the 32P-labeled cDNA probe corresponding to part of GKAP42 (nucleotides 854-1063). Hybridization was performed in 50% formamide, 4× SSC, 0.5% SDS, 5× Denhardt's solution, and 100 µg/ml salmon sperm DNA with the probe at 42 °C for 16 h. The membrane was washed finally with 0.2× SSC and 0.1% SDS at 60 °C for 1 h and exposed to x-ray film at -70 °C for 2 days.

Preparation of Recombinant GKAP42 Protein and Antibody-- A cDNA encoding part of GKAP42 (amino acids 1-337) was subcloned into the site of the glutathione S-transferase (GST) expression vector pGEX-5X-3 (Amersham Pharmacia Biotech), generating pGEX-GKAP42. The GST fusion protein construct pGEX-GKAP42 was introduced into the bacterial strain JM109 (TOYOBO, Japan). An overnight culture in LB medium was diluted 1:100 into 100 ml of fresh LB medium and incubated at 37 °C in a shaking incubator for 2 h. After isopropyl-1-thio-beta -D-galactopyranoside was added to the culture to a final concentration of 0.2 mM, the culture was incubated for an additional 2 h. The cells were washed once with ice-cold soluble buffer (50 mM Tris-HCl, pH 8.0, and 1 mM EDTA) and resuspended in 5 ml of ice-cold soluble buffer containing 10 mg/ml aprotinin, 10 mM leupeptin, and 1 mM dithiothreitol. After freezing and thawing, suspended cells were sonicated on ice in short bursts. The lysate was cleared by centrifugation at 16,000 × g for 15 min at 4 °C. The supernatant was then incubated with glutathione-Sepharose 4B (Amersham Pharmacia Biotech) for 2 h at 4 °C. The beads were settled by centrifugation at 700 × g, washed five times with ice-cold soluble buffer, and incubated with 10 mM reduced glutathione for 10 min at 4 °C to elute GST-GKAP42 fusion protein from the beads. After centrifugation, the supernatant was dialyzed against phosphate-buffered saline (PBS). Polyclonal antibody raised against GKAP42 was obtained by injecting rabbits with GST-GKAP42 fusion protein in Freund's complete adjuvant.

In Situ Hybridization-- Freshly dissected 9-week ICR mouse testes were fixed for 6 h in Bouin's solution and embedded in paraffin. Four-µm sections were cut and mounted on Superfrost Plus slides (Fisher). In situ hybridization using digoxigenin-labeled probes was performed as described previously (20). Digoxigenin-labeled cRNA probes (antisense and sense) were made by in vitro transcription using cDNAs subcloned into the pGEM-T vector as templates in the presence of digoxigenin-labeled dUTP (Roche Molecular Biochemicals, Mannheim, Germany) according to the manufacturer's instructions. After paraffin was removed with xylene, tissues were given two 5-min washes in 0.1 M phosphate buffer, pH 7.2; treated with 0.001% proteinase K (Roche Molecular Biochemicals); and subsequently incubated for 10 min with a solution of 0.1 M triethanolamine and 0.225% anhydrous acetic acid. After being washed with 0.1 M phosphate buffer, sections were dehydrated through a series of increasing concentrations of ethanol and air-dried. The sections were prehybridized for 1 h at 50 °C in hybridization buffer (10% sodium dextran sulfate, 20 mM Tris-HCl, pH 8.0, 0.3 M NaCl, 0.2% sarcosyl, 0.02% heat-denatured salmon sperm DNA, 1× Denhardt's solution, and 50% formamide) and then hybridized overnight at 50 °C in hybridization buffer with 100 ng/ml cRNA probe. After being rinsed in 5× SSC at 60 °C for 20 min, the sections were washed with 50% formamide and 2× SSC at 60 °C for 30 min. Next, they were subjected to RNase digestion for 20 min at 37 °C (1 µg/ml RNase A in buffer containing 10 mM Tris-HCl, 1 mM EDTA, and 0.5 M NaCl, pH 7.5) and then washed with 50% formamide and 2× SSC at 60 °C for 30 min. For detection of hybridized cRNA probes, anti-digoxigenin antibody conjugated to alkaline phosphatase (Roche Molecular Biochemicals) was reacted at 1:500, and color was developed by incubation with 4-nitro blue tetrazolium chloride and X-phosphate solution.

Immunoprecipitation of Endogenous GKAP42 and cGK-I from Mouse Testis-- ICR mouse testis was homogenized in TNE buffer (10 mM Tris-HCl, pH 7.5, 1% Nonidet P-40, 1 mM EDTA, 0.15 M NaCl, 10 mg/ml aprotinin, 10 mM leupeptin, and 1 mM dithiothreitol). The homogenates were centrifuged at 50,000 × g for 30 min at 4 °C. The resulting supernatants were filtrated with a 0.45-µm filter (Millipore) and immunoprecipitated with 10 µg of either anti-GKAP42 polyclonal antibody or normal rabbit IgG with protein G-Sepharose overnight at 4 °C by rotation. The beads were washed five times with TNE buffer, and immune complexes were eluted by heating at 95 °C in 2× SDS sample buffer, subjected to SDS-PAGE, and analyzed by immunoblotting with anti-cGK-I polyclonal antibody (Calbiochem).

In Vitro cGK Kinase Assay-- COS-7 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 100 units/ml penicillin, and 100 µg/ml streptomycin at 37 °C in 5% CO2. The full-length cGK-Ialpha cDNA and GKAP42 cDNA in the expression vector pFLAG-CMV-2 (Eastman Kodak Co.) were transiently expressed in COS-7 cells using LipofectAMINE Plus reagent (Life Technologies, Inc.) following the manufacturer's instructions. Twenty-four h after transfection, cells were washed twice with ice-cold PBS and scraped into ice-cold TNE buffer. Cell extracts were centrifuged at 16,000 × g for 15 min at 4 °C to remove cellular debris. The supernatants were immunoprecipitated with anti-FLAG antibody M5 (Kodak) with protein G-Sepharose overnight at 4 °C by rotation. The beads were washed five times with TNE buffer, and the immunoprecipitated samples were used for the in vitro kinase assay.

Protein kinase assays were performed in kinase reaction buffer (50 mM Tris-HCl, pH 7.5, 20 mM magnesium acetate, 0.2 mM [gamma -32P]ATP, 2 µM protein kinase A inhibitor peptide-(5-24), 5 mM glycerophosphoric acid, and 1 mM sodium orthovanadate) in the presence of 100 µM BPDEide (Calbiochem), a synthetic substrate selective for cGK. Reactions were performed in the presence or absence of cGMP (5 µM final concentration). Assays were conducted at 30 °C for 30 min and terminated by centrifuging and aliquoting the peptide onto phosphocellulose P-81 paper (Whatman). The phosphocellulose pads were washed five times with 0.5% phosphoric acid and counted using a Fuji BAS2000 imaging analyzer. The values represent the -fold activation over the cGK activity of the lysates from mock-transfected cells taken as 1 and are expressed as the mean of three independent experiments. Phosphorylation of GKAP42 by cGK in vitro was performed in kinase reaction buffer with or without 5 µM cGMP. Phosphorylation by cAK was performed in the same buffer, but in the presence or absence of 2 µM protein kinase A inhibitor peptide-(5-24). The samples were incubated at 30 °C for 30 min and centrifuged at 16,000 × g at 4 °C. The beads were mixed with an equal volume of 2× SDS sample buffer and heated at 95 °C for 5 min, and the denatured proteins were loaded on SDS-polyacrylamide gels. The gels were dried and subjected to autoradiography at -80 °C.

Immunofluorescence Microscopy-- COS-7 cells grown on cover glasses were cotransfected with the full-length GKAP42 cDNA in the expression vector pCMV-EGFPC1 (CLONTECH) and/or pFLAG-cGK-Ialpha . After 24 h, the cells were directly fixed with 4% paraformaldehyde and 4% sucrose in 0.2 M NaPO4, pH 7.2, for 30 min and blocked with 1.5% normal goat serum in PBS for 1 h at room temperature. Cells were treated with anti-FLAG antibody M5 (diluted 1:500 in PBS with 0.1% Tween 20) for 1 h at room temperature and washed five times with PBS. The primary antibody was visualized with FluoroLinkTM CyTM3-labeled goat anti-mouse IgG (Amersham Pharmacia Biotech). Two monoclonal antibodies raised against the Golgi zone were purchased from Biogenesis (Bournemouth, United Kingdom) and Chemicon International, Inc. (Temecula, CA) and used for immunofluorescence microscopy.

Phosphorylation of GKAP42 in Vivo-- COS-7 cells were cotransfected with pFLAG-cGK-Ialpha and pFLAG-GKAP42 as described above. After treatment in the presence or absence of 8-CPT-cGMP (Sigma) for 30 min, cells were scraped into ice-cold radioimmune precipitation assay buffer (50 mM Tris-HCl, pH 7.5, 0.1% Triton X-100, 0.15 M NaCl, 0.1% SDS, 1% Nonidet P-40, 2 mM EDTA, 10 µg/ml aprotinin, 10 µM leupeptin, 25 mM glycerophosphoric acid, and 1 mM sodium orthovanadate). The cell extracts were centrifuged at 16,000 × g for 15 min at 4 °C to remove cellular debris, and the supernatants were subjected to SDS-PAGE and analyzed by immunoblotting using anti-FLAG antibody M5.

In Vivo Binding Analysis-- The full-length cGK-Ialpha cDNA in pFLAG-CMV-2 and the full-length GKAP42 cDNA in pcDNA3.1/His (Invitrogen) were transiently expressed in COS-7 cells as described above. After treatment in the presence or absence of 8-CPT-cGMP for 30 min, cells were scraped into ice-cold TNE buffer. Cell extracts were centrifuged at 16,000 × g for 15 min at 4 °C to remove cellular debris. The supernatants were immunoprecipitated with anti-Xpress polyclonal antibody (Santa Cruz Biotechnology) with protein G-Sepharose in the presence or absence of 8-CPT-cGMP for 4 h at 4 °C by rotation. The beads were washed five times with TNE buffer, and immune complexes were eluted by heating at 95 °C in 2× SDS sample buffer, subjected to SDS-PAGE, and analyzed by immunoblotting with anti-FLAG antibody M5.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Identification of a Novel cGK-Ialpha -interacting Protein by Two-hybrid Screening in Yeast-- The recent reports (9, 10) that the type II regulatory subunits of cAK (cAK-RII) are able to associate with AKAPs raise the possibility that the regulatory domain located in the N terminus of cGK interacts with cGK-specific anchoring proteins. To identify potential components of cGK signaling, we performed yeast two-hybrid screening. An expression vector that encodes the N-terminal region of bovine cGK-Ialpha (amino acids 1-416) fused to the GAL4 DNA-binding domain (GAL4-BD) was used as a bait in the yeast two-hybrid screening of a mouse 17-day embryo cDNA library. From the 1 × 105 transformants screened, three colonies were positive as determined by activation of the His3 reporter gene and the beta -galactosidase assay. As expected, two of the isolated cDNAs encoded mouse slow skeletal troponin T (14). Furthermore, we obtained one cDNA encoding a novel protein (GKAP42) as a true positive clone. To examine the specificity of the interaction between cGK-Ialpha and GKAP42 in the yeast two-hybrid system, full-length cGK-Ibeta , cGK-II, cAK-RIIalpha , and cAK-Calpha were fused to GAL4-BD and cotransformed with GKAP42. The yeast two-hybrid analysis demonstrated that only cGK-Ialpha can associate with GKAP42 (Fig. 1A). Expression of each GAL4-BD-fused protein was confirmed by immunoblot analysis using anti-GAL4-BD antibody (data not shown).


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 1.   cGK-Ialpha interacts with GKAP42 in the yeast two-hybrid system. A, specific interaction of cyclic nucleotide-dependent protein kinase families with GKAP42. The Y190 yeast strain was cotransformed with GAL4-BD fusion plasmid expressing cGK-Ialpha (pAS2-1-cGK-Ialpha ), cGK-Ibeta (pAS2-1-cGK-Ibeta ), cGK-II (pAS2-1-cGK-II), cAK-Calpha (pAS2-1-cAK-Calpha ), or cAK-RIIalpha (pAS2-1-cAK-RIIalpha ) in combination with GAL4-AD fusion plasmid expressing GKAP42 (pGAD-GKAP42). Following selection on leucine/tryptophan-negative plates, two independent colonies were isolated and assayed for the activation of beta -galactosidase (beta -gal). B, mapping of the GKAP42-binding sites in cGK-Ialpha . The Y190 yeast strain was cotransformed with the expression plasmid for GAL4-BD-cGK-Ialpha deletion mutants and GAL4-activation domain-GKAP42 and assayed for the activation of beta -galactosidase. The top bar illustrates the structure of cGK-Ialpha . The numbers preceding and following each line denote the positions of the most terminal amino acid residue of each clone.

To identify the region of cGK-Ialpha responsible for the interaction with GKAP42, we constructed a series of cGK-Ialpha deletion mutants and tested them for their ability to associate with GKAP42 in the yeast two-hybrid system. As shown in Fig. 1B, we found that the cGK-Ialpha domain required for interaction with GKAP42 is restricted to the N-terminal region between amino acids 1 and 66, containing the leucine zipper motif, a sequence of heptad repeats of leucines and isoleucines forming an alpha -helical structure.

The full-length cDNA of GKAP42 was isolated from a lambda -phage mouse lung cDNA library by conventional hybridization screening and contained an open reading frame of 1098 nucleotides that encodes a polypeptide of 366 amino acids with a calculated molecular mass of 41.8 kDa (Fig. 2A). The first methionine is surrounded by a Kozak consensus sequence. In the 3'-untranslated region of GKAP42, a typical polyadenylation signal, AATAAA (21), is found upstream of the poly(A)+ tail. A search of the GenBankTM Data Bank using the nucleotide and amino acid sequences revealed no significant similarity to other reported sequences. In addition, the predicted protein sequence does not contain a characteristic signal sequence at the N terminus or a transmembrane sequence as determined by hydropathy analysis. Secondary structure analysis for coiled-coils (19) predicted four stretches of coiled-coil structure (Fig. 2B). These structural features are thought to be involved in association with other proteins and/or homodimerization/homo-oligomerization.


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 2.   Nucleotide and deduced amino acid sequences of GKAP42 cDNA. A, the deduced amino acid sequences are shown in three-letter designation below the nucleotide sequence. The termination codon at the end of the open reading frame is represented by asterisks. The in-frame termination codon upstream of the initiation codon of the open reading frame is double-underlined. The boxed AATAAA sequence represents a putative polyadenylation signal. B, shown are the results from the coiled-coil analysis of GKAP42 by the COILS program.

Stage-specific Expression of GKAP42 in Testis-- Northern blot analysis was performed using poly(A)+ RNA derived from various mouse tissues and the GKAP42 cDNA fragment as a probe. A strong hybridization signal of ~1.5 kilobase pairs was predominantly or solely observed in testis (Fig. 3A). To identify the cell types in which GKAP42 mRNA is expressed, sections of adult mouse testis were hybridized in situ with the antisense RNA probe complementary to GKAP42 mRNA. Intense hybridization signals were detected in testicular germ cells at the stages of spermatocytes and round spermatids (Fig. 3B). No or little signal was detected in spermatogonia, late spermatids, and somatic Sertoli and Leydig cells. Furthermore, when the sense RNA was used as a control probe, no positive staining was observed (Fig. 3C).


View larger version (59K):
[in this window]
[in a new window]
 
Fig. 3.   Stage-specific expression of GKAP42 mRNA in testis. A, Northern blot of poly(A)+ RNAs from various mouse tissues. A mouse multiple-tissue Northern blot was hybridized using a 32P-labeled fragment of GKAP42 cDNA as described under "Experimental Procedures." The sizes (in kilobase pairs (kb)) and positions of mRNA size markers are shown. B and C, in situ localization of GKAP42 mRNA in mouse testis. Paraffin sections of adult mouse testis were hybridized with digoxigenin-labeled antisense (B) or sense (C) RNA probe complementary to GKAP42 mRNA as described "Experimental Procedures." For detection of hybridized cRNA probes, anti-digoxigenin antibody conjugated to alkaline phosphatase was reacted, and color was developed by incubation with 4-nitro blue tetrazolium chloride and X-phosphate solution.

Next, we prepared a polyclonal antibody against GKAP42 using a bacterially synthesized GST-fused fragment corresponding to amino acids 1-337 of GKAP42. The specificity of the anti-GKAP42 antibody was tested by immunoblot analysis of total proteins from COS-7 cells transfected with an expression vector encoding FLAG epitope-tagged GKAP42 (FLAG-GKAP42). Although no signal was observed in the mock-transfected cells, a specific band of ~42 kDa was detected in the cells transfected with a plasmid encoding FLAG-GKAP42 using both anti-GKAP42 and anti-FLAG antibodies (Fig. 4A). Furthermore, to determine whether the GKAP42 mRNA detected in germ cell is translated into a protein, immunoblot analysis was performed with total protein from mouse adult testis. Although the anti-GKAP42 antibody recognized an immunoreactive polypeptide of 42 kDa in the soluble fraction of the testis homogenate, GKAP42 protein was absent in the mature sperm prepared from mouse epididymis (Fig. 4B). Furthermore, attempts were made to determine whether endogenous cGK-I associates with GKAP42 under the physiological condition. Soluble fractions from adult mouse testis were immunoprecipitated with anti-GKAP42 antibody, and coprecipitating cGK-I was detected by immunoblot analysis using a polyclonal antibody against cGK-I. In this assay, GKAP42 was able to coprecipitate cGK-I (Fig. 4C), confirming the in vivo interaction detected by the yeast two-hybrid analysis.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 4.   Specificity of the anti-GKAP42 antibody and the physiological interaction between cGK-I and GKAP42 in mouse testis. A, the specificity of the anti-GKAP42 antibody. Cell lysates prepared from COS-7 cells transfected with either empty vector or the expression vector encoding FLAG-GKAP42 were subjected to SDS-PAGE. The gels were analyzed by immunoblotting with anti-FLAG (left panel) and anti-GKAP42 (right panel) antibodies. B, GKAP42 protein is absent from mature sperm. Immunoblot analysis was performed with total protein from mouse adult testis or mature sperm prepared from mouse epididymis using anti-GKAP42 antibody. C, the physiological interaction between cGK-I and GKAP42 in mouse testis. Soluble fractions from adult mouse testis were immunoprecipitated (IP) with anti-GKAP42 antibody, and the immunoprecipitate was analyzed by immunoblot analysis using anti-cGK-I polyclonal antibody.

Co-localization of cGK-I with GKAP42 in Mammalian Cells-- To identify whether cGK-Ialpha can form complexes with GKAP42 in mammalian cells and to determine the intracellular localization of cGK-Ialpha with or without GKAP42, the plasmid DNA encoding green fluorescence protein fused to full-length GKAP42 was constructed and cotransfected with FLAG epitope-tagged cGK-Ialpha into COS-7 cells. Immunofluorescence microscopy showed that in cells transfected with green fluorescence protein-GKAP42, GKAP42 was concentrated at juxtanuclear regions corresponding to the Golgi complex (Fig. 5, A and C) because of co-staining with anti-Golgi zone antibody (Fig. 5D). Although cGK-Ialpha was localized to the cytoplasm in cells transfected with FLAG-cGK-Ialpha alone (Fig. 5B), cGK-Ialpha was co-localized to the Golgi complex when coexpressed with GKAP42 (Fig. 5, E and F). These observations were consistent with the ability of cGK-Ialpha to interact with GKAP42 in vivo.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 5.   Co-localization of cGK-Ialpha with GKAP42 to the Golgi body. COS-7 cells were transiently transfected with green fluorescence protein (GFP)-GKAP42 (A, C, and D), FLAG-tagged cGK-Ialpha (B), or a combination of both (E and F). COS-7 cells were fixed and incubated with anti-FLAG or anti-Golgi zone antibody. The primary antibody was visualized with FluoroLinkTM CyTM3-labeled goat anti-mouse IgG, followed by fluorescence microscopy.

GKAP42 Is Specifically Phosphorylated by cGK-I-- Next, we examined the ability of GKAP42 protein to modulate cGK activity in vitro. cGK activity was measured by immune complex kinase assay using a synthetic substrate selective for cGK, BPDEide (22). However, overexpression of GKAP42 did not affect cGK activity independent of the presence or absence of cGMP (Fig. 6A), suggesting that the association with GKAP42 does not stimulate or inhibit cGK activity.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 6.   GKAP42 is specifically phosphorylated by cGK in vitro. A, association of GKAP42 does not influence cGK activity. COS-7 cells were transfected with empty vector or the vector expressing FLAG-cGK-Ialpha in combination with FLAG-GKAP42, and cell lysates were immunoprecipitated by anti-FLAG antibody. cGK activity was measured in the absence (-) or presence (+) of 5 µM cGMP using the synthetic peptide BPDEide. B, phosphorylation of GKAP42 by cGK-Ialpha and cGK-Ibeta in vitro. COS-7 cells were cotransfected with the expression plasmid for FLAG-cGK-Ialpha , the kinase-defective mutant FLAG-cGK-Ialpha D502A, or FLAG-cGK-Ibeta in combination with the vector expressing FLAG-GKAP42. Whole cell lysates were immunoprecipitated with anti-FLAG antibody, and cGK activity was measured in an in vitro kinase assay. Reactions were performed in the absence (-) or presence (+) of 5 µM cGMP. To monitor the expression level of each kinase, whole cell lysates were blotted with anti-FLAG antibody (Blot: Flag). C, phosphorylation of GKAP42 by cGK-Ialpha , but not by cAK. COS-7 cells were cotransfected with the expression plasmid for either FLAG-cGK-Ialpha or FLAG-cAK-Calpha in combination with the vector expressing FLAG-tagged cardiac troponin I or FLAG-GKAP42. WT, wild type.

Because many AKAPs are phosphorylated by cAK, we examined whether cGK-I would phosphorylate GKAP42. In vitro kinase assay using the immunoprecipitation complex showed that GKAP42 was phosphorylated by both cGK-Ialpha and cGK-Ibeta in a cGMP-dependent manner (Fig. 6B). Although cAK activity was confirmed by phosphorylation of cardiac troponin I, one of the substrates for both cGK and cAK, GKAP42 was not phosphorylated by cAK. A kinase-defective mutant of cGK-Ialpha , cGK-Ialpha D502A, in which aspartic acid 502 is changed to alanine (23), could not phosphorylate GKAP42, indicating that GKAP42 is a good substrate for only cGK-I isozymes in vitro (Fig. 6C). Additionally, we found that phosphorylation by cGK-Ialpha caused a slight shift in the mobility of GKAP42 protein during SDS-PAGE by in vitro kinase assay (data not shown). Because some substrates have been shown to be good substrates in vitro but not in vivo (24), we investigated the phosphorylation of GKAP42 by an in vivo kinase assay. For this purpose, we used FLAG-cGK-I and FLAG-GKAP42 and treated the cotransfected COS-7 cells with 8-CPT-cGMP, a cell-permeable analogue of cGMP. The cell extracts were subjected to SDS-PAGE and analyzed by immunoblotting using anti-FLAG antibody. The shift in the mobility of GKAP42 protein was cGMP-dependent only when cotransfected with wild-type cGK-Ialpha (Fig. 7A). Interestingly, cGK-Ibeta failed to phosphorylate GKAP42 in vivo. Taken together with the observation that cGK-Ibeta could not interact with GKAP42 in the yeast two-hybrid system, the direct interaction with the kinase protein is required for the phosphorylation in intact cells.


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 7.   Phosphorylation of GKAP42 by cGK-Ialpha in vivo. A, GKAP42 is specifically phosphorylated by cGK-Ialpha in vivo. COS-7 cells were cotransfected with the expression vector for FLAG-cGK-Ialpha , cGK-Ialpha D502A, or cGK-Ibeta in combination with the expression plasmid for FLAG-GKAP42. 24 h after transfection, cells were treated with (+) or without (-) 100 µM 8-CPT-cGMP for 30 min. The cell lysates were subjected to SDS-PAGE and analyzed by immunoblotting using anti-FLAG antibody. B, cGK-Ialpha phosphorylates at serine 106 in GKAP42. FLAG-cGK-Ialpha was coexpressed with wild-type GKAP42 (WT), GKAP42 S86A, GKAP42 S106A, or GKAP42 T178A in COS-7 cells. After treatment in the absence (-) or presence (+) of 8-CPT-cGMP for 30 min, the cell extracts were subjected to SDS-PAGE and analyzed by immunoblotting using anti-FLAG antibody.

Previous studies with peptide libraries defined optimal amino acid sequences (RKX(S/T), X is any amino acid) for phosphorylation by cGK (25). Although GKAP42 is preferentially phosphorylated by cGK-I in vitro and in vivo, a typical cGK phosphorylation site was not identified in GKAP42. To identify the cGK-I phosphorylation site of GKAP42, we constructed a series of GKAP42 deletion mutants and performed an in vitro kinase assay. cGK-Ialpha was shown to phosphorylate amino acids 71-199 of GKAP42 (data not shown). cGK-Ialpha was previously demonstrated to autophosphorylate primarily at threonine 58, which is an atypical cGK substrate sequence (IGPRTT58RAQGI). Glass and Smith (26) reported that the recognition site specificity of cGK requires an arginine located on the C-terminal side (underlined) of the phosphorylated residue, X(S/T)RX. Because GKAP42 also has this motif (PAQKES106REEN) in the region of amino acids 71-199, we prepared a mutant of GKAP42 (GKAP42 S106A) in which serine 106 is changed to alanine and tested it in both in vitro and in vivo kinase assays. The mutation S106A was shown to completely abolish the band shift in vitro (data not shown) and in vivo (Fig. 7B). In addition, mutation of a nearby residue, namely S86A or T178A, could not disrupt the potential phosphorylation by cGK-Ialpha .

In Vivo Interaction between cGK-I and GKAP42-- To determine whether cGK-Ialpha can interact with GKAP42 in mammalian cells, we carried out co-immunoprecipitation assays. An expression vector encoding Xpress epitope-tagged GKAP42 (Xpress-GKAP42) was transfected alone or with an expression vector encoding FLAG-cGK-Ialpha into COS-7 cells. The cell lysates were immunoprecipitated using anti-Xpress antibody, and coprecipitating cGK-Ialpha was detected by immunoblot analysis using anti-FLAG antibody. The ability of the anti-Xpress antibody to precipitate a complex of cGK-Ialpha and GKAP42 suggests that these two proteins strongly interact in vivo (Fig. 8). Next, to test whether kinase activity affects the interaction with GKAP42, we compared the interactions between GKAP42 and either wild-type cGK-Ialpha or a kinase-deficient mutant of cGK-Ialpha , cGK-Ialpha D502A. Interestingly, a stable interaction with kinase-negative cGK-Ialpha D502A was observed in mammalian cells. A previous report (29) has shown that mutations that led to the kinase-negative phenotype enhance the enzyme-substrate interaction. Taken together with the observation that GKAP42 is efficiently phosphorylated by wild-type cGK-Ialpha in vivo, the phosphorylation might result in the reduction of the stability of the interaction between the two proteins.


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 8.   In vivo interaction of cGK-Ialpha with GKAP42. COS-7 cells were cotransfected with pFLAG empty vector, pFLAG-cGK-Ialpha , or pFLAG-cGK-Ialpha D502A in combination with the plasmid expressing Xpress-GKAP42. 24 h after transfection, cells were treated with (+) or without (-) 100 µM 8-CPT-cGMP for 30 min. Whole cell lysates were separated by SDS-PAGE and then immunoblotted with anti-FLAG or anti-Xpress antibody. The same lysates were immunoprecipitated with anti-Xpress antibody, and the immunoprecipitates were blotted with anti-FLAG antibody. WT, wild type.

Recent reports have demonstrated that cGK-I undergoes a conformational change when cGMP binds to the cGMP-binding domains of cGK-I (27, 28). Finally, we examined the effect of the conformational change produced by cGMP on the interaction between cGK-Ialpha and GKAP42. When COS-7 cells cotransfected with cGK-Ialpha and GKAP42 were treated with 8-CPT-cGMP, the stability of the interaction between cGK-Ialpha and GKAP42 was reduced compared with no treatment. These results indicate that the binding of cGMP to cGK-Ialpha enables them to release from GKAP42.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In this study, a cDNA encoding a novel germ cell-specific protein was identified as a cGK-Ialpha -interacting protein by yeast two-hybrid screening using the N-terminal regulatory region of cGK-Ialpha as a bait, and we demonstrated the physiological interaction of these two proteins in testis tissue. We also showed that GKAP42 selectively associates with cGK-Ialpha and that the phosphorylation of GKAP42 seems to be dependent on direct interaction with the kinase protein. Very recently, we showed that troponin T functions as an anchoring protein for cGK-I and that cGK-I may participate in the regulation of muscle contraction through phosphorylation of troponin I (14). Similarly, troponin T protein does not interact with cGK-II or cAMP-dependent protein kinase, and the N-terminal region of cGK-I is essential for the association with troponin T, but the interaction between cGK-I and troponin T is not substantially affected by the activation state of cGK-I. One characteristic feature of the interaction with GKAP42 is that cGMP induces the release of cGK-Ialpha from GKAP42. In this respect, GKAP42 seems to be similar to AKAPs, which bind cAK via its regulator subunits. However, the catalytic subunits of cAK are released from regulatory subunits in response to intracellular cAMP elevation, suggesting that there is a distinct mechanism underlying the detachment of the regulatory domain of cGK-Ialpha from GKAP42. In addition, a kinase-inactive mutant of cGK-Ialpha also could dissociate from GKAP42 in response to cGMP binding. This observation suggests that the mechanism underlying cGMP-induced release of cGK-Ialpha from GKAP42 is not dependent on the increase in basal kinase activity or autophosphorylation in the presence of cGMP. Recent studies (27, 28) showed that cGMP binding to cGK-I produces distinct conformational changes in the enzyme as evidenced by increased surface electronegativity, a larger Stokes radius, decreased mobility on native gel electrophoresis, and altered susceptibility to protease, suggesting that the conformational change in the presence of cGMP reduces the stability of this interaction. Another feature is that a kinase-inactive mutant of cGK-Ialpha stably associates with GKAP42 in the basal state. The transcription factor MEF2C was isolated by yeast two-hybrid screening using a dead kinase of p38 mitogen-activated protein kinase (29). Taken together with the fact that the in vitro binding of MEF2C to wild-type p38 was not detected when a large excess of ATP was included, the stability of this interaction appears to be reduced after phosphorylation of MEF2C. In fact, GKAP42 protein is efficiently phosphorylated by cGK-Ialpha both in vitro and in vivo, but in the presence of cGMP. Supposedly, the minor autophosphorylation of cGK-Ialpha in the absence of cGMP might reduce the stability of this interaction. As noted also, GKAP42 was efficiently phosphorylated by cGK. Because cGK and cAK have many overlapping consensus phosphorylation motifs, proteins identified as substrates for cGK are often efficiently phosphorylated by cAK in vitro. Only very few substrates of cGK are more specifically phosphorylated by cGK than by cAK. These include the G-substrate (30), cGMP-binding phosphodiesterase (PDE5) (22), one phosphorylation site in VASP (31), and cAK-RI (32), all of which have ~10-fold selectivity relative to cAK. Previous studies with peptide libraries defined optimal amino acid sequences for phosphorylation by cGK (RKX(S/T)) (25). Additionally, Glass and Smith (26) reported that the recognition site specific to cGK requires an arginine on the C-terminal side (underlined) of the phosphorylated residue, X(S/T)RX. In fact, an autophosphorylation site (IGPRTT58RAQGI) in cGK-Ialpha fits this motif. Although GKAP42 does not contain a typical cGK phosphorylation site (RKX(S/T)), an arginine located on the C-terminal side of serine 106 (PAQKES106REEN) might be involved in the potential phosphorylation at serine 106 in vivo. Furthermore, we demonstrated that the association with GKAP42 is selective for cGK-Ialpha in a family of cyclic nucleotide-dependent protein kinases. More important, two isozymes of cGK-I (Ialpha and Ibeta ), produced by alternative splicing, differ in their N-terminal domains (amino acids 1-89 and 1-104, respectively), resulting in the specificity of interaction with GKAP42. Previous reports on AKAPs described differential subcellular localization of the isozymes likely due to specificity of the anchoring proteins. cAK-RIIalpha has a 6-fold increased affinity for microtubule-associated protein 2, and cAK-RIIbeta has a 2-fold affinity for AKAP75 (33). Furthermore, a few AKAPs, dual-specificity AKAPs, interact with both type I and II regulatory subunits (34, 35), whereas most AKAPs interact specifically with type II regulatory subunits. An added level of specificity in cAK signaling may be achieved thorough the differential localization of regulatory subunit isoforms by association with isoform-selective AKAPs. Likewise, the N-terminal domain of cGK-I isozymes, through the interaction with their anchoring proteins, may play an important role in the determination of subcellular localization, leading to the mediation of isozyme-specific functions.

One of the intriguing observations of this study is that GKAP42 is located in the Golgi complex. Recently, a number of Golgi-associated proteins have been isolated by antibodies from patients with autoimmune diseases and by antibodies prepared in animals. These include giantin or GCP372 (36), golgin-245 or p230 (37), GCP230 (38), GM130 or golgin-95 (39), and GCP170 (golgin-160) or male-enhanced antigen-2 (40). Although giantin/GCP372 is an integral membrane protein anchored to the membrane by the C-terminal hydrophobic domain, all the other proteins have no hydrophobic domain that could function as a signal sequence or participate in membrane localization. The common characteristic of all these proteins is a very large domain, enabling the formation of coiled-coil structures analogous to the myosin family. One of the predicted structural features of GKAP42 is a long helical domain that is very likely to form a coiled-coil structure. To date, the Golgi complex is considered to play a crucial role in the formation of acrosomes and the chromatoid body in male germ cells. The acrosome is a specialized membrane-bound organelle located in the head of sperm cells that contains a rich store of hydrolytic enzymes and that is crucial for fertilization (41). Very recently, male mice bearing a null mutation of golgin-160 (male-enhanced antigen-2) were reported to be sterile due to a block of spermatogenesis, showing apparent scarcity of spermatids and spermatozoa (42). Although spermatogenesis in the homozygotes proceeded at least to meiotic metaphase I, deformation of condensed nuclei was evident in elongated spermatids, suggesting the important roles of Golgi-associated proteins during spermatogenesis. On the other hand, although a large number of studies have reported that NO or natriuretic peptides/cGMP pathways play an important role in the nervous, cardiovascular, and immune systems of various species, information concerning the cGMP-dependent signaling pathway in germ cells is still limited. Recently, a cyclic nucleotide-gated channel was identified in mammalian sperm, and cyclic nucleotide-gated channels have been demonstrated to be directly opened by either cGMP or cAMP and are permeable to Ca2+ ions (43). Although a rise in the cellular Ca2+ concentration has been proposed to alter sperm motility and to trigger the acrosomal reaction, the acrosomal exocytosis of spermatozoa induced by natriuretic peptides is dependent on Ca2+ influx and the protein kinase C signaling pathway, but not on the cGK signaling pathway (44). Recently, several works have focused on the cAMP signaling pathway during sperm differentiation. Although studies on mice lacking the transcription factor CREM, a nuclear target of cAK, have indicated an important role for the cAMP-dependent pathway in spermatid differentiation (45, 46), the adenylyl cyclase (47) and type 4 cAMP-specific phosphodiesterase (48) are co-localized in the acrosomal membrane, suggesting one functional region for the cAMP signaling pathway during spermatogenesis. Furthermore, a variety of AKAPs, including AKAP82 (49), AKAP84 (50), AKAP110 (51), and AKAP121 (52), have been identified in testis. The introduction of anchoring inhibitor peptides designed to disrupt the interaction of cAK with AKAPs inhibited sperm motility (53). AKAP82 and AKAP84 are localized in the flagellum, suggesting that they are involved in the assembly of the fibrous sheath surrounding the axoneme and in sperm motility. Taken together with the previous immunohistochemical analysis showing the presence of cGK-I protein in rat spermatocytes (54), the current study suggests that cGK-Ialpha might participate in germ cell development through phosphorylation of Golgi-associated proteins such as GKAP42.

    ACKNOWLEDGEMENTS

We thank Drs. T. M. Lincoln, M. Fujii, D. Ayusawa, and Y. Maeda for generous gifts of cDNAs. We are grateful to Drs. H. Imahie and K. Kobayashi for technical assistance and Dr. H. Sakurai for helpful discussion.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AB033130.

To whom correspondence should be addressed. Fax: 81-6-6300-2593; E-mail: n-yanaka@tanabe.co.jp.

    ABBREVIATIONS

The abbreviations used are: cGKs, cGMP-dependent protein kinases; GKAP, cGMP-dependent protein kinase-anchoring protein; cAK, cAMP-dependent protein kinase; AKAP, A kinase-anchoring protein; cAK-R, cAK regulatory subunit; cAK-C, cAK catalytic subunit; PCR, polymerase chain reaction; GST, glutathione S-transferase; PBS, phosphate-buffered saline; PAGE, polyacrylamide gel electrophoresis; 8-CPT-cGMP, 8-(4-chlorophenylthio)guanosine 3':5'-monophosphate; GAL4-BD, GAL4 DNA-binding domain.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Hofmann, F., Dostmann, W., Keilbach, A., Landgraf, W., and Ruth, P. (1992) Biochim. Biophys. Acta 1135, 51-60[Medline] [Order article via Infotrieve]
2. Pfeifer, A., Aszódi, A., Seidler, U., Ruth, P., Hofmann, F., and Fässler, R. (1996) Science 274, 2082-2086[Abstract/Free Full Text]
3. Lohmann, S. M., Vaandrager, A. B., Smolenski, A., Walter, U., and DeJonge, H. R. (1997) Trends Biochem. Sci. 22, 307-312[CrossRef][Medline] [Order article via Infotrieve]
4. Pfeifer, A., Klatt, P., Massberg, S., Ny, L., Sausbier, M., Hirneiß, C., Wang, G.-X., Korth, M., Aszódi, A., Andersson, K.-E., Krombach, F., Mayerhofer, A., Ruth, P., Fässler, R., and Hofmann, F. (1998) EMBO J. 17, 3045-3051[CrossRef][Medline] [Order article via Infotrieve]
5. Wernet, W., Flockerzi, V., and Hofmann, F. (1989) FEBS Lett. 251, 191-196[CrossRef][Medline] [Order article via Infotrieve]
6. Takio, K., Wade, R. D., Smith, S. B., Krebs, E. G., Walsh, K. A., and Titani, K. (1984) Biochemistry 23, 4207-4218[CrossRef][Medline] [Order article via Infotrieve]
7. Mochly-Rosen, D. (1995) Science 268, 247-251[Abstract/Free Full Text]
8. Pawson, T., and Scott, J. D. (1997) Science 278, 2075-2080[Abstract/Free Full Text]
9. Dell'Acqua, M. L., and Scott, J. D. (1997) J. Biol. Chem. 272, 12881-12884[Free Full Text]
10. Hausken, Z. E., Coghlan, V. M., Hastings, C. A. S., Reimann, E. M., and Scott, J. D. (1994) J. Biol. Chem. 269, 24245-24251[Abstract/Free Full Text]
11. Mochly-Rosen, D., and Gordon, A. S. (1998) FASEB J. 12, 35-42[Abstract/Free Full Text]
12. Ron, D., Chen, C.-H., Caldwell, J., Jamieson, L., Orr, E., and Mochly-Rosen, D. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 839-843[Abstract/Free Full Text]
13. Fu, H., Xia, K., Pallas, D. C., Cui, C., Conroy, K., Narsimhan, R. P., Mamon, H., Collier, R. J., and Roberts, T. M. (1994) Science 266, 126-129[Abstract/Free Full Text]
14. Yuasa, K., Michibata, H., Omori, K., and Yanaka, N. (1999) J. Biol. Chem. 274, 37429-37434[Abstract/Free Full Text]
15. Sandberg, M., Natarajan, V., Ronander, I., Kalderon, D., Walter, U., Lohmann, S. M., and Jahnsen, T. (1989) FEBS Lett. 255, 321-329[CrossRef][Medline] [Order article via Infotrieve]
16. Scott, J. D., Glaccum, M. B., Zoller, M. J., Uhler, M. D., Helfman, D. M., McKnight, G. S., and Krebs, E. G. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 5192-5196[Abstract/Free Full Text]
17. Øyen, O., Myklebust, F., Scott, J. D., Hansson, V., and Jahnsen, T. (1989) FEBS Lett. 246, 57-64[CrossRef][Medline] [Order article via Infotrieve]
18. Uhler, M. D., Carmichael, D. F., Lee, D. C., Chrivia, J. C., Krebs, E. G., and McKnight, G. S. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 1300-1304[Abstract/Free Full Text]
19. Lupas, A., VanDyke, M., and Stock, J. (1991) Science 252, 1162-1164[Free Full Text]
20. Imaizumi, K., Tsuda, M., Wanaka, A., Tohyama, M., and Takagi, T. (1994) Mol. Brain Res. 26, 189-196[Medline] [Order article via Infotrieve]
21. Proudfoot, N. J., and Brownlee, G. G. (1976) Nature 263, 211-214[CrossRef][Medline] [Order article via Infotrieve]
22. Colbran, J. L., Francis, S. H., Leach, A. B., Thomas, M. K., Jiang, H., McAllister, L. M., and Corbin, J. D. (1992) J. Biol. Chem. 267, 9589-9594[Abstract/Free Full Text]
23. Gudi, T., Lohmann, S. M., and Pilz, R. B. (1997) Mol. Cell. Biol. 17, 5244-5254[Abstract]
24. Huggins, J. P., Cook, E. A., Piggott, J. R., Mattinsley, T. J., and England, P. J. (1989) Biochem. J. 260, 829-835[Medline] [Order article via Infotrieve]
25. Tegge, W., Frank, R., Hofmann, F., and Dostmann, W. R. G. (1995) Biochemistry 34, 10569-10577[CrossRef][Medline] [Order article via Infotrieve]
26. Glass, D. B., and Smith, S. B. (1983) J. Biol. Chem. 258, 14797-14803[Abstract/Free Full Text]
27. Chu, D.-M., Corbin, J. D., Grimes, K. A., and Francis, S. H. (1997) J. Biol. Chem. 272, 31922-31928[Abstract/Free Full Text]
28. Zhao, J., Trewhella, J., Corbin, J., Francis, S., Mitchell, R., Brushia, R., and Walsh, D. (1997) J. Biol. Chem. 272, 31929-31936[Abstract/Free Full Text]
29. Han, J., Jiang, Y., Li, Z., Kravchenko, V. V., and Ulevitch, R. J. (1997) Nature 386, 296-299[CrossRef][Medline] [Order article via Infotrieve]
30. Hall, K. U., Collins, S. P., Gamm, D. M., Massa, E., DePaoli-Roach, A. A., and Uhler, M. D. (1999) J. Biol. Chem. 274, 3485-3495[Abstract/Free Full Text]
31. Butt, E., Abel, K., Krieger, M., Palm, D., Hoppe, V., Hoppe, J., and Walter, U. (1994) J. Biol. Chem. 269, 14509-14517[Abstract/Free Full Text]
32. Geahlen, R. L., and Krebs, E. G. (1980) J. Biol. Chem. 255, 1164-1169[Abstract/Free Full Text]
33. Leiser, M., Rubin, C. S., and Erlichman, J. (1986) J. Biol. Chem. 261, 1904-1908[Abstract/Free Full Text]
34. Huang, L. J., Durick, K., Weiner, J. A., Chun, J., and Taylor, S. S. (1997) J. Biol. Chem. 272, 8057-8064[Abstract/Free Full Text]
35. Huang, L. J., Durick, K., Weiner, J. A., Chun, J., and Taylor, S. S. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 11184-11189[Abstract/Free Full Text]
36. Linstedt, A. D., and Hauri, H. P. (1993) Mol. Biol. Cell 4, 679-693[Abstract]
37. Fritzler, M. J., Lung, C.-C., Hamel, J. C., Griffith, K. J., and Chan, E. K. L. (1995) J. Biol. Chem. 270, 31262-31268[Abstract/Free Full Text]
38. Funaki, T., Fujiwara, T., Hong, H. S., Misumi, Y., Nishioka, M., and Ikehara, Y. (1996) Cell Struct. Funct. 21, 63-72[Medline] [Order article via Infotrieve]
39. Nakamura, N., Rabouille, C., Watson, R., Nilsson, T., Hui, N., Slusarewicz, P., Kreis, T. E., and Warren, G. (1995) J. Cell Biol. 131, 1715-1726[Abstract/Free Full Text]
40. Misumi, Y., Sohda, M., Yano, A., Fujiwara, T., and Ikehara, Y. (1997) J. Biol. Chem. 272, 23851-23858[Abstract/Free Full Text]
41. Thorne-Tjomsland, G., Clermont, Y., and Hermo, L. (1988) Anat. Rec. 221, 591-598[CrossRef][Medline] [Order article via Infotrieve]
42. Matsukuma, S., Kondo, M., Yoshihara, M., Matsuda, M., Utakoji, T., and Sutou, S. (1999) Mamm. Genome 10, 1-5[CrossRef][Medline] [Order article via Infotrieve]
43. Weyand, I., Godde, M., Frings, S., Weiner, J., Müller, F., Altenhofen, W., Hatt, H., and Kaupp, U. B. (1994) Nature 368, 859-863[CrossRef][Medline] [Order article via Infotrieve]
44. Rotem, R., Zamir, N., Keynan, N., Barkan, D., Breitbart, H., and Naor, Z. (1998) Am. J. Physiol. 274, E218-E223[Abstract/Free Full Text]
45. Nantel, F., Monaco, L., Foulkes, N. S., Masquilier, D., LeMeur, M., Henriksén, K., Dierich, A., Parvinen, M., and Sassone-Corsi, P. (1996) Nature 380, 159-162[CrossRef][Medline] [Order article via Infotrieve]
46. Blendy, J. A., Kaestner, K. H., Weinbauer, G. F., Nieschlag, E., and Schütz, G. (1996) Nature 380, 162-165[CrossRef][Medline] [Order article via Infotrieve]
47. Gautier-Courteille, C., Salanova, M., and Conti, M. (1998) Endocrinology 139, 2588-2599[Abstract/Free Full Text]
48. Salanova, M., Chun, S.-Y., Iona, S., Puri, C., Stefanini, M., and Conti, M. (1999) Endocrinology 140, 2297-2306[Abstract/Free Full Text]
49. Johnson, L. R., Foster, J. A., Haig-Ladewig, L., VanScoy, H., Rubin, C. S., Moss, S. B., and Gerton, G. L. (1997) Dev. Biol. 192, 340-350[CrossRef][Medline] [Order article via Infotrieve]
50. Lin, R.-Y., Moss, S. B., and Rubin, C. S. (1995) J. Biol. Chem. 270, 27804-27811[Abstract/Free Full Text]
51. Vijayaraghavan, S., Liberty, G. A., Mohan, J., Winfrey, V. P., Olson, G. E., and Carr, D. W. (1999) Mol. Endocrinol. 13, 705-717[Abstract/Free Full Text]
52. Chen, Q., Lin, R.-Y., and Rubin, C. S. (1997) J. Biol. Chem. 272, 15247-15257[Abstract/Free Full Text]
53. Vijayaraghavan, S., Goueli, S. A., Davey, M. P., and Carr, D. W. (1997) J. Biol. Chem. 272, 4747-4752[Abstract/Free Full Text]
54. Spruill, W. A., Koide, Y., Huang, H.-L., Levine, S. N., Ong, S.-H., Steiner, A. L., and Beavo, J. A. (1981) Endocrinology 109, 2239-2248[Abstract/Free Full Text]


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
Y.-H. Huang, C.-C. Wei, Y.-H. Su, B.-T. Wu, Y.-Y. Ciou, C.-F. Tu, T. G. Cooper, C.-H. Yeung, S.-T. Chu, M.-T. Tsai, et al.
Localization and Characterization of an Orphan Receptor, Guanylyl Cyclase-G, in Mouse Testis and Sperm
Endocrinology, October 1, 2006; 147(10): 4792 - 4800.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
D. M. Raizen, K. M. Cullison, A. I. Pack, and M. V. Sundaram
A Novel Gain-of-Function Mutant of the Cyclic GMP-Dependent Protein Kinase egl-4 Affects Multiple Physiological Processes in Caenorhabditis elegans
Genetics, May 1, 2006; 173(1): 177 - 187.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. E. Casteel, G. R. Boss, and R. B. Pilz
Identification of the Interface between cGMP-dependent Protein Kinase I{beta} and Its Interaction Partners TFII-I and IRAG Reveals a Common Interaction Motif
J. Biol. Chem., November 18, 2005; 280(46): 38211 - 38218.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Cha, J. H. Kim, H. Hut, B. M. Hogema, J. Nadarja, M. Zizak, M. Cavet, W. Lee-Kwon, S. M. Lohmann, A. Smolenski, et al.
cGMP Inhibition of Na+/H+ Antiporter 3 (NHE3) Requires PDZ Domain Adapter NHERF2, a Broad Specificity Protein Kinase G-anchoring Protein
J. Biol. Chem., April 29, 2005; 280(17): 16642 - 16650.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
F. Shi and T. Wang
Stage- and Cell-Specific Expression of Soluble Guanylyl Cyclase Alpha and Beta Subunits, cGMP-Dependent Protein Kinase I Alpha and Beta, and Cyclic Nucleotide-Gated Channel Subunit 1 in the Rat Testis
J Androl, March 1, 2005; 26(2): 258 - 263.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Muller, A. K. Mukhopadhyay, R. C. Speth, G. Guidone, R. Potthast, L. R. Potter, and R. Middendorff
Spatiotemporal Regulation of the Two Atrial Natriuretic Peptide Receptors in Testis
Endocrinology, March 1, 2004; 145(3): 1392 - 1401.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Richie-Jannetta, S. H. Francis, and J. D. Corbin
Dimerization of cGMP-dependent Protein Kinase I{beta} Is Mediated by an Extensive Amino-terminal Leucine Zipper Motif, and Dimerization Modulates Enzyme Function
J. Biol. Chem., December 12, 2003; 278(50): 50070 - 50079.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Yanaka, Y. Imai, E. Kawai, H. Akatsuka, K. Wakimoto, Y. Nogusa, N. Kato, H. Chiba, E. Kotani, K. Omori, et al.
Novel Membrane Protein Containing Glycerophosphodiester Phosphodiesterase Motif Is Transiently Expressed during Osteoblast Differentiation
J. Biol. Chem., October 31, 2003; 278(44): 43595 - 43602.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. E. Wall, S. H. Francis, J. D. Corbin, K. Grimes, R. Richie-Jannetta, J. Kotera, B. A. Macdonald, R. R. Gibson, and J. Trewhella
Mechanisms associated with cGMP binding and activation of cGMP-dependent protein kinase
PNAS, March 4, 2003; 100(5): 2380 - 2385.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
M. Xu, J. Xiao, J. Chen, J. Li, L. Yin, H. Zhu, Z. Zhou, and J. Sha
Identification and characterization of a novel human testis-specific Golgi protein, NYD-SP12
Mol. Hum. Reprod., January 1, 2003; 9(1): 9 - 17.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Zaragoza, E. Soria, E. Lopez, D. Browning, M. Balbin, C. Lopez-Otin, and S. Lamas
Activation of the Mitogen Activated Protein Kinase Extracellular Signal-Regulated Kinase 1 and 2 by the Nitric Oxide-cGMP-cGMP-Dependent Protein Kinase Axis Regulates the Expression of Matrix Metalloproteinase 13 in Vascular Endothelial Cells
Mol. Pharmacol., October 1, 2002; 62(4): 927 - 935.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. E. Casteel, S. Zhuang, T. Gudi, J. Tang, M. Vuica, S. Desiderio, and R. B. Pilz
cGMP-dependent Protein Kinase Ibeta Physically and Functionally Interacts with the Transcriptional Regulator TFII-I
J. Biol. Chem., August 23, 2002; 277(35): 32003 - 32014.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Yanaka, K. Kobayashi, K. Wakimoto, E. Yamada, H. Imahie, Y. Imai, and C. Mori
Insertional Mutation of the Murine Kisimo Locus Caused a Defect in Spermatogenesis
J. Biol. Chem., May 12, 2000; 275(20): 14791 - 14794.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Yuasa, J. Kotera, K. Fujishige, H. Michibata, T. Sasaki, and K. Omori
Isolation and Characterization of Two Novel Phosphodiesterase PDE11A Variants Showing Unique Structure and Tissue-specific Expression
J. Biol. Chem., September 29, 2000; 275(40): 31469 - 31479.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. D. Browning, M. Mc Shane, C. Marty, and R. D. Ye
Functional Analysis of Type 1alpha cGMP-dependent Protein Kinase Using Green Fluorescent Fusion Proteins
J. Biol. Chem., April 13, 2001; 276(16): 13039 - 13048.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Ammendola, A. Geiselhoringer, F. Hofmann, and J. Schlossmann
Molecular Determinants of the Interaction between the Inositol 1,4,5-Trisphosphate Receptor-associated cGMP Kinase Substrate (IRAG) and cGMP Kinase Ibeta
J. Biol. Chem., June 22, 2001; 276(26): 24153 - 24159.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yuasa, K.
Right arrow Articles by Yanaka, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yuasa, K.
Right arrow Articles by Yanaka, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement